Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

29 trials with published results (25%)

Research Maturity

72 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

1.7%

2 terminated out of 116 trials

Success Rate

97.3%

+10.8% vs benchmark

Late-Stage Pipeline

9%

10 trials in Phase 3/4

Results Transparency

40%

29 of 72 completed with results

Key Signals

29 with results97% success

Data Visualizations

Phase Distribution

99Total
Not Applicable (75)
P 1 (1)
P 2 (13)
P 4 (10)

Trial Status

Completed72
Unknown27
Withdrawn6
Recruiting4
Active Not Recruiting3
Terminated2

Trial Success Rate

97.3%

Benchmark: 86.5%

Based on 72 completed trials

Clinical Trials (116)

Showing 20 of 20 trials
NCT06220474Not ApplicableRecruiting

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

NCT05577910Not ApplicableCompletedPrimary

Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD

NCT06004895Not ApplicableCompleted

Mechanisms of Light-based Therapies for Dry Eye Disease

NCT06483750Not ApplicableCompleted

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

NCT06371300Not ApplicableRecruiting

Photobiomodulation With REd vs BluE Light (REBEL)

NCT04425551Not ApplicableCompleted

Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction

NCT04795752Not ApplicableCompleted

Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)

NCT03857919Not ApplicableCompleted

TearCare System to Treat Dry Eye Disease

NCT05454956Phase 2CompletedPrimary

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD

NCT06064071Not ApplicableActive Not RecruitingPrimary

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

NCT03461978Not ApplicableCompletedPrimary

Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures

NCT03162497Phase 4Completed

Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction

NCT03767530Not ApplicableRecruitingPrimary

Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction

NCT01207752Not ApplicableCompletedPrimary

The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction

NCT06163105Not ApplicableCompletedPrimary

The Effect of Gland Expression on the Regeneration of Meibomian Gland

NCT05162261Not ApplicableCompletedPrimary

to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction

NCT06745089Not ApplicableCompleted

Treatment Effect of Intense Pulsed Light and Thermal Pulsation Therapy on Meibomian Gland Dysfunction-associated Dry Eye Disease: a Randomized Trial

NCT04889950Not ApplicableCompleted

Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction

NCT06525961Phase 4Not Yet Recruiting

iTear Single-center, Open-label, Single-arm Study

NCT06520007CompletedPrimary

Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction

Scroll to load more

Research Network

Activity Timeline